Cargando…

Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective study

Post-progression survival affects overall survival (OS) in patients with HER2-negative advanced breast cancer (HER2-ABC); thus, the optimal choice of first-line chemotherapy (1LCT) remains controversial. We investigated patients with HER2-ABC focusing on their sensitivity to 1LCT. We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamoto, Shogo, Watanabe, Junichiro, Ohtani, Shoichiro, Morita, Satoshi, Ikeda, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563944/ https://www.ncbi.nlm.nih.gov/pubmed/34728668 http://dx.doi.org/10.1038/s41598-021-00711-x

Ejemplares similares

Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: a multicenter retrospective study
por: Nakamoto, Shogo, et al.
Publicado: (2022)

What about drinking is associated with shorter life in poorer people?
por: Rehm, Jürgen, et al.
Publicado: (2018)

Systemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer
por: Nakamoto, Shogo, et al.
Publicado: (2021)

Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2021)

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2021)

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2022)

Shorter Anogenital Distance Predicts Poorer Semen Quality in Young Men in Rochester, New York
por: Mendiola, Jaime, et al.
Publicado: (2011)

Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression
por: Rampersaud, Ryan, et al.
Publicado: (2023)

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study
por: Ueno, Takayuki, et al.
Publicado: (2019)

Are Psychotic Experiences Related to Poorer Reflective Reasoning?
por: Mækelæ, Martin J., et al.
Publicado: (2018)

Sleep in lonely heroin-dependent patients receiving methadone maintenance treatment: longer sleep latency, shorter sleep duration, lower sleep efficiency, and poorer sleep quality
por: Li, Hong-Jie, et al.
Publicado: (2017)

Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis
por: Lobefaro, Riccardo, et al.
Publicado: (2020)

Reversing the Trends toward Shorter Lives and Poorer Health for U.S. Women: A Call for Innovative Interdisciplinary Research
por: Schweinhart, April, et al.
Publicado: (2018)

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
por: Yamashiro, Hiroyasu, et al.
Publicado: (2018)

Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan
por: Kikawa, Yuichiro, et al.
Publicado: (2019)

A review of patients discharged from Shannon Clinic- are shorter stays in secure hospitals associated with poorer patient outcomes?
por: Grimason, Amy, et al.
Publicado: (2021)

Shorter spontaneous fixation durations in infants with later emerging autism
por: Wass, Sam V., et al.
Publicado: (2015)

Suboptimal Sleep Duration is Associated with Poorer Neuroimaging Brain Health Profiles
por: Clocchiatti-Tuozzo, Santiago, et al.
Publicado: (2023)

Shorter sleep duration and better sleep quality are associated with greater tissue density in the brain
por: Takeuchi, Hikaru, et al.
Publicado: (2018)

Shorter respiratory event duration is related to prevalence of type 2 diabetes
por: Guo, Junwei, et al.
Publicado: (2023)

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
por: Fukada, Ippei, et al.
Publicado: (2021)

Duration of anti-SARS-CoV-2 antibodies much shorter in India
por: Kumar, Nishant, et al.
Publicado: (2021)

Shorter mothers have shorter pregnancies
por: Derraik, José, et al.
Publicado: (2015)

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
por: Masuda, Norikazu, et al.
Publicado: (2021)

Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study
por: Taniyama, Yusuke, et al.
Publicado: (2021)

Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review
por: Watanabe, Junichiro
Publicado: (2015)

Later Age of Onset and Longer Duration of Untreated Psychosis are Associated with Poorer Outcome in Delusional Infestation
por: LEPPING, Peter, et al.
Publicado: (2020)

Corneal Cross-Linking: Evaluating the Potential for a Lower Power, Shorter Duration Treatment
por: Caruso, Ciro, et al.
Publicado: (2016)

Young age and shorter duration of Crohn’s disease are associated with non-adherence to taking medication
por: Yilmaz, Hasan
Publicado: (2022)

Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
por: Gupta, Shruti, et al.
Publicado: (2022)

Maximizing QRS duration reduction in contemporary cardiac resynchronization therapy is feasible and shorter QRS duration is associated with better clinical outcome
por: Borgquist, Rasmus, et al.
Publicado: (2023)

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
por: Tokunaga, Eriko, et al.
Publicado: (2021)

Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration
por: Hawro, Tomasz, et al.
Publicado: (2010)

Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
por: Chang, Mineok, et al.
Publicado: (2014)

Shorter Duration of Post-Operative Antibiotics for Cecal Ligation and Puncture Does Not Increase Inflammation or Mortality
por: Iskander, Kendra N., et al.
Publicado: (2016)

Shorter fixation durations for up-directed saccades during saccadic exploration: A meta-analysis
por: Greene, Harold H, et al.
Publicado: (2020)

Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
por: Winters, Nicholas, et al.
Publicado: (2023)

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
por: Huang, Yi-Teng, et al.
Publicado: (2013)

Expression of ribosome-binding protein 1 correlates with shorter survival in Her-2 positive breast cancer
por: Liang, Xiaoshuan, et al.
Publicado: (2015)

The duration aftereffect does not reflect adaptation to perceived duration
por: Maarseveen, Jim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pq96i8uhoqa22tm8u79iso9c5b